| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |